Objective: To examine the expression absence of LRRC4 gene in glioblastoma cell lines.
Methods: RT-PCR and Northern blot were used to detect the expression of LRRC4 gene in 6 glioblastomas cells lines. Polymerase chain reaction and DNA sequencing were used to screen the LRRC4 gene mutation, while bioinformation assay was used to search for the reason of LRRC4 gene absence in U251 cell lines.
Results: The expression of LRRC4 was absent in 6 malignant glioma cell lines (U251, U87, BT325, SF126, SF767 and M17), which were examined by Northern-blot and RT-PCR assay. All sequencing of PCR products from gDNA of SF126, SF767, and M17 cell lines contained the point mutation at the same position ( LRRC4 geneT977A) (3/5), which was a synonymous mutation. However, PCR products from gDNA of U251 and U87 cell lines (2/5) were not obtained. The expression absence of LRRC4 was ascribed to the loss of homozygosity of 7q32-ter in U251 cell lines.
Conclusion: The expression of LRRC4 gene is absent in glioblastoma cell lines, and it offers the important experiment proof for LRRC4 to act as a new candidate of brain tumor suppressor gene from glioma. The loss of homozygosity of 7q32-ter contributed to the expression absence of LRRC4 in U251 cell lines.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Multimodal Pancreatic Cancer Detection Using Methylated DNA Biomarkers in Pancreatic Juice and Plasma CA 19-9: A Prospective Multicenter Study.
Clin Gastroenterol Hepatol
October 2024
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. Electronic address:
Article Synopsis
- A multicenter study aimed to evaluate the effectiveness of methylated DNA markers (MDMs) found in pancreatic juice (PJ) for detecting pancreatic ductal adenocarcinoma (PDAC) when used alone and in combination with a blood test, CA 19-9.
- The analysis included DNA samples from 88 confirmed PDAC cases and 134 control cases, utilizing logistic regression to summarize accuracy through the area under the receiver-operating characteristic curve (AUROC).
- Results showed that the combination model of PJ-MDMs and CA 19-9 achieved a higher accuracy (AUROC of 0.95) compared to using PJ-MDMs (0.87) or CA 19-9 alone (0
Insights into brain tumor diagnosis: exploring hybridization techniques.
Front Neurol
July 2024
Department of Pathophysiology, First Moscow State Medical University (Sechenov University), Moscow, Russia.
Objectives: Diagnosing brain tumors is critical due to their complex nature. This review explores the potential of hybridization for diagnosing brain neoplasms, examining their attributes and applications in neurology and oncology.
Methods: The review surveys literature and cross-references findings with the OMIM database, examining 513 records.
Genome-wide CRISPRi Screen in Human iNeurons to Identify Novel Focal Cortical Dysplasia Genes.
bioRxiv
December 2023
Department of Neurology, University of Michigan Medical School, Ann Arbor, MI.
Focal cortical dysplasia (FCD) is a common cause of focal epilepsy that typically results from brain mosaic mutations in the mTOR cell signaling pathway. To identify new FCD genes, we developed an CRISPRi screen in human neurons and used FACS enrichment based on the FCD biomarker, phosphorylated S6 ribosomal protein (pS6). Using whole-genome (110,000 gRNAs) and candidate (129 gRNAs) libraries, we discovered 12 new genes that significantly increase pS6 levels.
View Article and Find Full Text PDFA Massively Parallel Screen of 5'UTR Mutations Identifies Variants Impacting Translation and Protein Production in Neurodevelopmental Disorder Genes.
medRxiv
November 2023
Department of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA.
mutations cause a variety of neurodevelopmental disorders including autism. Recent whole genome sequencing from individuals with autism has shown that many mutations also occur in untranslated regions (UTRs) of genes, but it is difficult to predict from sequence alone which mutations are functional, let alone causal. Therefore, we developed a high throughput assay to screen the transcriptional and translational effects of 997 variants from 5'UTR patient mutations.
View Article and Find Full Text PDFWhole genome sequencing identifies genetic variants associated with neurogenic inflammation in rosacea.
Nat Commun
July 2023
Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Article Synopsis
- Rosacea is a common inflammatory skin disorder linked to genetic factors, but the specific genes involved are not well understood.
- Researchers conducted whole genome sequencing on three large families and additional whole exome sequencing on 49 families, identifying rare genetic variants in genes like LRRC4, SH3PXD2A, and SLC26A8 associated with rosacea.
- Functional analysis showed these gene mutations lead to increased production of neuropeptides and inflammation in skin similar to rosacea, highlighting the role of familial inheritance and neurogenic processes in the disorder's development.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!